<html>
<head>PUBMED IDs for GLYT1</head>
<body bgcolor='#C5F0F2'><h1>GLYT1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15925702/'>Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion.</a> June 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16143353/'>Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.</a> September 7  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17582620/'>The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder.</a> June 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18798526/'>Glycine transporters and synaptic function.</a> September 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19219857/'>Genetic association studies of methamphetamine use disorders: A systematic review and synthesis.</a> February 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20123783/'>Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage.</a> July 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/27773429/'>Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.</a> May 20  2016<br></body></html>
